English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The aim of this study was to determine the effect of royal jelly on albumin and bilirubin levels in 1000 mg / day dosesmoking addicts with controlled experimental design. For this purpose, Fagerström Nicotine Dependence Scale was applied to smokers, a total of 20 adult male cigarette addicts (n = 10) with high addiction scores (6-7 points) were included in the study and the cigarette addict experimental group (n = 10) taking royal jelly supplementation. Criteria such as smoking and dependence of the individuals included in the study, not having any disease and not having allergies to honey derived foods were determined and groups were formed in this way. The experimental group was given liquid royal jelly (n = 10/1000 mg /day) supplemented in glass vials in the refrigerator at the same time every morning for three weeks. No application was made to the control group. In order to determine albumin and bilirubin levels in both groups, blood samples were analyzed one day before and one day after the study. SPSS 22.0 package program was used for statistical analysis of measured data of experimental and control groups. For the analysis of the measured data of the experimental and control groups, 2x2 mixed factor ANOVA and LSD tests were performed. Statistical results were evaluated at p <0,05 significance level. In the analysis of the levels of albumin and bilirubin between the pre-test and post-test of the experimental group receiving royal jelly supplementation and the nonsupplemented control group, no statistical significance was found (p> 0,05). In the intergroup analysis of the two groups, again no significant difference was found (p> 0,05). As a result of this study, it can be said that royal jelly supplementation at a dose of 1000 mg / day for 21 days does not affect albumin and bilirubin levels in cigarette addicts.

ARE ALBUMIN AND BILIRUBIN VALUES OF SMOKERS AFFECTED BY ROYAL JELLY SUPPLEMENT?